In particular what do you think it will do to personal savings, pensions and general wealth?
The likely outcome is that the US tariff policy in general (NB not the tariffs on imports from Ireland specifically) will lead to an immediate fall in equity markets, and lower future growth in equity markets than would otherwise be the case. As to how big a fall, and how much lower growth — that's hard to say. Apart from anything else, it depends on events which have yet to happen.
The impact of this on "personal savings, pensions and general wealth" will be negative. Savings wholly or partly invested in equities, directly or indirectly, will be the most affected.
As for the tariffs on Irish imports in particular — will there be an additional effect in Ireland? Yes, and it will be negative, but again it's hard to be precise.
The major Irish exports to the US are:
- pharmaceuticals and chemicals (dwarfing everything else)
- technical, medical, etc apparatus
- machinery
- electrical and electronic equipment
- aircraft
- food and drink products
Obviously, not all of these things are actually manufactured here. If, e.g. the massive Irish aviation leasing industry is adversely affected, that'll impact the relatively small number of people engaged in that industry, but the effect will be limited to them. But if food, drink or pharmaceutical exports to the US are reduced — yeah, that could potentially affect a lot of people, both those employed in the industry and the businesses that serve the industry and its workers.
But how exactly this will roll out is still uncertain. You might think that with a 20% tariff on pharmaceuticals, a lot of pharmaceutical production will relocate to places that suffer only the 10% tariff, or a zero tariff, or to the US itself. But that's not something that can happen quickly — pharmaceutical production facilities are both technically challenging and enormously expensive to construct; you don't relocate them on a whim. Trump being Trump, it's entirely possible that these tariffs will be varied again, or he will just call them off and claim a huge victory, or he'll do an about-face when the impact of the tariffs on the US cost of living means he's looking at the Republicans being whipped to a puree in the mid-term elections. Or whatever. The point is, the pharma business needs the dust to settle and some long-term stability to emerge before making major investment decisions. In the meantime they may just suck up the tariffs and the impact on sales. So it may be some time before we really know how this is going to pan out for Ireland.
It's also worth pointing out, as an additional complicating factor, that the tariffs only affect Irish exports
to the US. Sticking with pharma again, we have pharma exports to the US of about US$32 billion. That looks like a lot, but we have
total pharma exports of $92 billion. Even if pharma exports to the US were halved because of the tariffs — and I think that's probably a very high estimate — that means a fall in total pharma exports of US$16 billion, or 17.4%. High, no doubt, but it would still leave us as one of the largest pharma exporters in the world.